Biotech Acquisition (OTCMKTS:BIOTU) Stock Price Down 7.7% – Should You Sell?

Biotech Acquisition (OTCMKTS:BIOTUGet Free Report)’s share price fell 7.7% during trading on Friday . The stock traded as low as $10.14 and last traded at $10.14. 1,300 shares were traded during trading, a decline of 71% from the average session volume of 4,444 shares. The stock had previously closed at $10.98.

Biotech Acquisition Stock Performance

The company has a 50 day moving average of $10.14 and a 200 day moving average of $10.14.

About Biotech Acquisition

(Get Free Report)

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Read More

Receive News & Ratings for Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.